PRTN3 and rheumatoid arthritis: In conclusion, this long-term real-world study using the TRACER database demonstrated that bio-naïve status, latent TB infection, and RF/ACPA seropositivity were potential predictors for 3-year drug retention of bDMARDs and tsDMARDs in RA.